Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
Post
-
-
TRiCares begins US IDE pivotal trial of TTVR system
TRiCares SAS has enrolled and treated the first patient in its TRICURE US IDE pivotal study of the Topaz transcatheter …
-
FDA clears Quoin Pharmaceuticals’ QRX003 IND for Phase II PSS trial
Quoin Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA) for its investigational new drug (IND) application …
-
Apertura and NIH institutes to test gene therapy for NPC1
Apertura has entered a cooperative research and development agreement (CRADA) with various NIH institutes for a gene therapy to treat …
-
Philips expands ultrasound portfolio with AI-driven Alturion
Philips has expanded its ultrasound portfolio with the launch of the Alturion system, which features AI-powered workflows and is intended …
-
First patient receives Forzinity in Mighty Therapeutics’ Phase IV study
Mighty Therapeutics has dosed the first patient in 4TAZPower, its global Phase IV confirmatory study assessing Forzinity (elamipretide) injection in …
-
Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
-
Evogene and Tel Aviv University launch drug discovery initiative
Evogene and Tel Aviv University’s Blavatnik Center for Drug Discovery (BCDD) have announced a collaboration that aims to expedite the …
-
First patient enrolled in AtaCor’s ALARION-EV trial of EV-ICD system
AtaCor Medical has enrolled the first patient in its ALARION-EV pivotal trial, which is evaluating an investigational extravascular implantable cardioverter-defibrillator …
-
Prilenia and Ferrer begin Phase III trial of Huntington’s therapy
Prilenia Therapeutics and Ferrer have begun the confirmatory Phase III PRECISE-HD clinical trial assessing pridopidine as a potential treatment for …
-
Biocytogen and Whitehawk partner to develop ADCs
Biocytogen and Whitehawk Therapeutics are set to develop bispecific antibody-drug conjugates (BsADCs), as part of a global partnership. Under this collaboration, …
-
Neo Medical launches Instant MIS Access platform in US
Swiss spine surgery company Neo Medical has commercially launched the Neo Instant MIS Access platform in the US. The platform is …
-
Ionis Pharmaceuticals concludes REVEAL study pivotal cohort enrolment
Ionis Pharmaceuticals has concluded enrolment in the pivotal cohort (Cohort 1) of its Phase III REVEAL study of obudanersen (ION582) …
-
EC approves AbbVie’s Tepkinly combination for follicular lymphoma
The European Commission (EC) has granted marketing authorisation for AbbVie’s Tepkinly (epcoritamab) in combination with lenalidomide and rituximab (Tepkinly + …
-
Zydus and Apollo Hospitals sign MoU to launch MCD test in India
Zydus Lifesciences has entered a memorandum of understanding (MoU) with Apollo Hospitals to expand access to the Shield multi-cancer detection …
-
Brii Bio reports end-of-treatment results for ENRICH and ENHANCE studies
Brii Biosciences (Brii Bio) has reported topline end-of-treatment (EOT) data from its ongoing Phase IIb ENRICH and ENHANCE trials assessing sequential …
-
Besins Healthcare boosts drug delivery portfolio with UniD deal
Besins Healthcare has expanded its pharmaceutical operations with the acquisition of Belgium-based UniD Manufacturing, which specialises in long-acting drug delivery …
